WeVote
Log In

Bill

Bill

SB 34

Prescription drugs; creating the Access to Lifesaving Medicines Act; prohibiting certain costs and requiring rebates under certain plans. Effective date.

2026 Regular Session Introduced by Carri Hicks

SB 34 prohibits specific prescription drug cost-sharing practices and requires health plans to pass rebates through to consumers, aiming to increase medication affordability.

Second Reading referred to Business and Insurance
0
WeVote Research Nonpartisan
Bill Summary · SB 34

Legislative bill overview

SB 34 aims to regulate prescription drug costs by prohibiting certain cost-sharing arrangements and mandating rebate requirements for health plans. The bill establishes protections intended to make essential medications more accessible and affordable for Oklahoma residents by restricting how insurers and pharmaceutical companies can structure pricing.

Why is this important

Prescription drug affordability is a critical healthcare policy issue affecting millions of Oklahomans, particularly those with chronic conditions. High out-of-pocket costs can prevent people from filling prescriptions, directly impacting public health outcomes and creating financial hardship for families.

Potential points of contention

  • Rebate pass-through requirements - Pharmaceutical companies and insurers may argue that mandating rebates reduces their flexibility in pricing negotiations and could ultimately increase base drug prices
  • Market impact concerns - Critics worry that restricting certain cost structures could reduce competition or innovation incentives in the pharmaceutical market
  • Implementation and enforcement - Unclear definitions of "certain costs" and which plans are covered may create regulatory challenges and unintended consequences for insurers operating in Oklahoma

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.